Published in Health Business Week, April 13th, 2007
The offering was managed by Morgan Stanley & Co. Incorporated and UBS Securities LLC as joint book-running managers.
Keywords: Abiomed, Inc., Abiomed Inc., Biotechnology Business, Biotechnology...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.